tetano
Editor, Senior Moderator
Front Pharmacol
. 2020 Aug 27;11:1327.
doi: 10.3389/fphar.2020.01327. eCollection 2020.
Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
Chunsheng Zhu[SUP] 1 [/SUP], Bao Sun[SUP] 2 [/SUP], Xiaochuan Zhang[SUP] 1 [/SUP], Bing Zhang[SUP] 3 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and currently affects more than 8 million people worldwide. SARS-CoV-2 mainly invades the cells by binding to the angiotensin converting enzyme 2 (ACE2) receptor, leading to the injury of respiratory system, cardiovascular system, digestive system, and urinary system, and even secondary to acute respiratory distress syndrome (ARDS) and systemic inflammatory response, resulting in multiple organ failure. In this review, mainly focusing on biogenesis and pathogenic mechanisms, we describe the recent progress in our understanding of SARS-CoV-2 and then summarize and discuss its crucial clinical characteristics and potential mechanism in different systems. Additionally, we discuss the potential treatments for COVID-19, aiming at a better understanding of the pathogenesis of SARS-CoV-2 and providing new ideas for the personalized treatment of COVID-19.
Keywords: angiotensin converting enzyme 2; coronavirus disease 2019; cytokine storm; pathogenic mechanism; severe acute respiratory syndrome coronavirus-2.
. 2020 Aug 27;11:1327.
doi: 10.3389/fphar.2020.01327. eCollection 2020.
Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
Chunsheng Zhu[SUP] 1 [/SUP], Bao Sun[SUP] 2 [/SUP], Xiaochuan Zhang[SUP] 1 [/SUP], Bing Zhang[SUP] 3 [/SUP]
Affiliations
- PMID: 32973534
- PMCID: PMC7482523
- DOI: 10.3389/fphar.2020.01327
Abstract
Coronavirus disease 2019 (COVID-19) is a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and currently affects more than 8 million people worldwide. SARS-CoV-2 mainly invades the cells by binding to the angiotensin converting enzyme 2 (ACE2) receptor, leading to the injury of respiratory system, cardiovascular system, digestive system, and urinary system, and even secondary to acute respiratory distress syndrome (ARDS) and systemic inflammatory response, resulting in multiple organ failure. In this review, mainly focusing on biogenesis and pathogenic mechanisms, we describe the recent progress in our understanding of SARS-CoV-2 and then summarize and discuss its crucial clinical characteristics and potential mechanism in different systems. Additionally, we discuss the potential treatments for COVID-19, aiming at a better understanding of the pathogenesis of SARS-CoV-2 and providing new ideas for the personalized treatment of COVID-19.
Keywords: angiotensin converting enzyme 2; coronavirus disease 2019; cytokine storm; pathogenic mechanism; severe acute respiratory syndrome coronavirus-2.